Regulation of transcription elongation by RNA polymerase II (Pol II) is a key regulatory step in gene transcription. Recently, the little elongation complex (LEC)-which contains the transcription elongation factor ELL/EAF-was found to be required for the transcription of Pol II-dependent small nuclear RNA (snRNA) genes. Here, we show that the human Mediator subunit MED26 plays a role in the recruitment of LEC to a subset of snRNA genes through direct interaction of EAF and the N-terminal domain (NTD) of MED26. Loss of MED26 in cells decreases the occupancy of LEC at a subset of snRNA genes and results in a reduction in their transcription. Our results suggest that the MED26 NTD functions as a molecular switch in the exchange of TBP-associated factor 7 (TAF7) for LEC in order to facilitate the transition from initiation to elongation during transcription of a subset of snRNA genes.
Introduction
Transcription by RNA polymerase II (Pol II) proceeds through multiple stages, beginning with recruitment of Pol II and other components of the transcription apparatus to the promoter in order to form a preinitiation complex, followed by ATP-dependent unwinding of the DNA template and transcription initiation. Following initiation, Pol II moves away from the promoter, leading to establishment of a productive elongation complex that can complete synthesis of the nascent transcript. Although research for many years was mainly focused on mechanisms that control the preinitiation and initiation stages of transcription [1] [2] [3] , a growing body of evidence indicates that transcription of many genes is also regulated during transcription elongation 4, 5 .
The product of the members of the eleven-nineteen lysine-rich leukemia (ELL) gene, which is a translocation partner of mixed lineage leukemia (MLL), and its binding partner ELL-associated factors (EAFs) are key regulator of transcription elongation by Pol II 6, 7 .
4 contain a 3'-box instead of a polyadenylation signal, which is required for 3' end formation 15 .
Transcription of Pol II-transcribed snRNA genes requires an integrator complex that specifically binds to the Ser7-phosphorylated form of the Pol II CTD and proceeds to the 3'end formation 16, 17 . Inhibitors of P-TEFb reduce the 3'-box-dependent 3'end processing but do not affect transcription elongation of the snRNA genes 18 , indicating that there is different regulation of transcription elongation between Pol II-dependent protein-coding genes and snRNA genes.
Mediator is an evolutionarily conserved transcriptional coregulatory complex that is needed for the relay of regulatory signals between gene-specific transcription activators and the basal initiation machinery 19 . Recently, it has been shown that Mediator is involved in the activation of transcription of a number of Pol II-dependent genes at multiple steps, including pre-initiation, promoter clearance, transcription elongation, transcription termination and mRNA splicing steps [20] [21] [22] [23] [24] . In metazoan, Mediator is composed of ~30 distinct subunits and exists in multiple and functionally distinct forms that share common core subunits, which are distinguished by the presence or absence of a kinase module composed of Cyclin C, CDK8, MED12 and MED13 25 .
Notably, a subset of Mediator contains an additional subunit, MED26. MED26-containing
Mediator is copurified with only a small amount of a kinase module but with sub-stoichiometric Pol II, and it plays an important role in gene activation [25] [26] [27] . The N-terminal domain (NTD) of MED26 is the most highly conserved region of MED26 and is similar to the NTDs of the elongation factors TFIIS and Elongin A 28, 29 . Previously, we found that MED26 NTD copurifies with two ELL/EAF-containing complexes, SEC and LEC 20 . We showed that MED26 NTD contributes to recruitment of SEC to a subset of human protein-coding genes including c-Myc and Hsp70 through direct interaction of MED26 NTD with EAF 20 . However, generality of the role of MED26 in recruiting ELL/EAF-containing complexes has not been established.
Here, we present evidence that the human Mediator subunit MED26 plays a role in the 5 recruitment of LEC to a subset of Pol II-transcribed snRNA genes through direct interaction of EAF and MED26 NTD. Depletion of MED26 in cells decreases the occupancy of LEC at a subset of snRNA genes and results in reduction of expression of the genes. In addition, we identified the MED26 NTD binding region of EAF1. Intriguingly, we found that there is a partially similar amino acid sequence in EAF and TBP-associated factor 7 (TAF7) and that each of the regions is necessary for direct interaction with MED26 NTD. TAF7 has been shown to repress the initiation or post-initiation process of transcription by preventing premature transcription initiation or elongation in a TFIID-dependent or independent manner 30, 31 . Our results indicate that TAF7 directly interacts with MED26 NTD and blocks LEC recruitment to a subset of snRNA genes. Based on our findings, we propose a model in which MED26 NTD functions as a molecular switch that interacts with TAF7 in the initiation process and then exchanges it for LEC to facilitate the transition from initiation to elongation during transcription of a subset of snRNA genes.
Results

NTD of MED26 is required for interaction with LEC
Since previous mass spectrometric analysis indicated that MED26 NTD interacts with LEC 20 ,
we performed Western blotting to determine whether MED26 NTD is critical for LEC interaction with Mediator. We purified Mediator from HeLa S3 cells stably expressing FLAG-tagged MED26 wild type (WT) or a MED26 NTD deletion mutant (CS: 421-600).
Mediator purified through FLAG-MED26-WT or MED26-CS was copurified with Pol II and Mediator components; however, deletion of MED26 NTD resulted in loss of Mediator interaction with LEC components, ICE1 (KIAA0947), ELL and EAF1 (Fig. 1a) . Since we previously showed that substitution of two amino acid residues R61 and K62 of MED26 NTD with A interferes with both direct interaction with EAF and interaction with the components of SEC in cells 20 , we tested whether the same substitution interferes with the interaction of MED26 NTD and LEC in cells. FLAG-MED26-WT was copurified with LEC, but MED26-R61A, K62A was not (Fig. 1b) . These results show that MED26 NTD is critical for interaction of Mediator with LEC. In turn, we tested whether LEC is copurified with MED26-containing Mediator. We purified LEC from 293FRT cells stably expressing FLAG-tagged ICE2 (NARG2).
FLAG-ICE2 was copurified with Mediator subunits MED26 and MED1, in addition to ICE1, ELL and EAF1 (Fig. 1c) , but FLAG-BTBD19 was not copurified with any of these proteins (Fig. 1c) , indicating that LEC interacts with MED26-containing Mediator. Taken together, the results indicate that MED26 NTD functions as a docking site for LEC to recruit it to Mediator.
Purification and reconstitution of little elongation complex
To address the interactions of individual factors within LEC, we expressed FLAG-ICE2, HA-ICE1, HA-ELL and Myc-EAF1 in the indicated combinations using a baculovirus expression system. FLAG-ICE2 was copurified with HA-ELL only in the presence of HA-ICE1
( Fig. 2a) , indicating that ICE1 is required for formation of the protein complex containing ICE1, ICE2 and ELL. Furthermore, HA-ICE1 was copurified with Myc-EAF1 only in the presence of FLAG-ELL (Fig. 2b) , indicating that ELL is required for formation of the protein complex containing ICE1, ELL and EAF1. FLAG-ICE2 was copurified with HA-ELL and Myc-EAF1 in the presence of HA-ICE1 (Fig. 2c) , indicating that ICE1 is required for formation of the protein complex containing ICE1, ICE2, ELL and EAF1. These results raised the possibility that the largest subunit of LEC, ICE1, functions as a core subunit and connects ICE2 and ELL/EAF for the formation of LEC. Considering that EAF1 directly interacts with MED26 NTD 20 , the EAF family protein is thought to function as an adaptor molecule to connect MED26 NTD and LEC (Fig. 2d) .
To clarify the region of ICE1 critical for the direct interaction with ICE2 and ELL respectively, we generated recombinant proteins of two truncate mutants of ICE1. The C-terminal fragment of ICE1 (CL: 1191-2266) bound to ICE2, but the N-terminal fragment of ICE1 (NL: 1-1190) did not ( Supplementary Fig. 1a ). On the other hand, both NL and CL of ICE1 bound to ELL ( Supplementary Fig. 1b ). These results indicate that the C-terminal fragment of ICE1 is sufficient for the formation of LEC. Consistent with these results, FLAG-tagged ICE1-CL purified from 293FRT cells stably expressing FLAG-ICE1-CL was copurified with LEC components ELL and EAF1 and with Mediator subunits MED26 and MED1 ( Supplementary Fig. 1c ). Taken together, these findings suggest that the C-terminal fragment of ICE1 (CL: 1191-2266) functions as a core region for the formation of LEC.
LEC enhances transcription elongation of Pol II in vitro
To determine whether LEC activates transcription elongation activity of Pol II, we reconstituted LEC using a baculovirus expression system. Since it was difficult to express a sufficient amount of full-length ICE1 (FL: 1-2266) for transcription assays, we used the C-terminal fragment of ICE1 (CL: 1191-2266). HA-ICE1-CL/FLAG-ICE2/FLAG-ELL/Myc-EAF1 complex was reconstituted by a baculovirus expression system (Fig. 2e) , and in vitro transcription elongation assays were performed to determine whether the complex stimulates Pol II transcription elongation. We used a linearized plasmid with a single-stranded 3' oligo(dC)-tail on its template strand. Although purified Pol II is unable to bind to double-stranded DNA and initiate transcription without assistance from the general transcription factors, it binds to the single-stranded oligo(dC)-tail and initiates transcription specifically at the junction between the single-and double-stranded regions of the template. In the template, the first nontemplate strand (dT) residue is 136 nt downstream of the oligo(dC)-tail, and the next run of (dT) residues is located ≈240 to ≈250 residues from the oligo(dC)-tail (Fig. 2f, HA-ICE1-CL/FLAG-ICE2/FLAG-ELL/Myc-EAF1 complex as indicated (Fig. 2f , lower left panel, lanes 2 and 3). When the complex was added with chase nucleotides, the fraction of Pol II that was able to read through the major pause site synthesized longer transcripts (Fig. 2f, lane 3). Quantification of the major paused transcript (#1) and the longer transcript (#2) supports our idea that reconstituted LEC helps Pol II to read through the major pause site and synthesize the longer transcript (Fig. 2f, lower (Fig. 4b ).
Significantly larger amounts of MED26, MED23 and MED1 were present at snRNA genes including U1-1, U4-1, U4-2, U5A and U5B than those at the upstream or downstream regions of the respective genes and U6 snRNA gene (Fig. 4b) . These results showed that Mediator was present at a subset of snRNA genes.
It was previously shown that LEC was colocalized at Cajal bodies 13 . Cajal bodies were shown to be the sites for not only pre-mRNA splicing but also transcription of snRNA genes 32 .
We therefore investigated whether MED26 was also colocalized with coilin, which is widely used as a molecular marker of Cajal bodies. We performed immunostaining of ICE1 and MED26 using HeLa cells. ICE1 was colocalized with coilin in Cajal bodies ( Supplementary Fig. 3 ). MED26 was stained diffusely in the nucleus and partly formed nuclear dots in which coilin was colocalized (Fig. 4c) . These results indicate that MED26-containing Mediator is colocalized with coilin at Cajal bodies and are consistent with our idea that MED26 has a role in transcription of snRNA genes.
MED26 is required for the expression of snRNA genes
To test whether depletion of MED26 affects the expression of snRNA genes, total RNAs were extracted from HEK293T cells that had been transfected with control siRNA or one of three different MED26 siRNAs ( Supplementary Fig. 4a ). qRT-PCR analysis revealed that the expression of a subset of snRNA and snoRNA genes, including U1, U2, U4-1, U4-2, U5A, U5B, U11 and snord118, was decreased following transfection of all three MED26 siRNAs, but the expression of U6 snRNA genes was not changed by depletion of MED26 (Fig. 5a ). These findings show that MED26 is required for the expression of snRNA genes.
To assess the potential contribution of MED26 NTD to the transcription of snRNA genes, we generated mouse embryonic fibroblast (MEF) cells from day 10.5 homozygous embryos in which a gene trapping construct had been inserted into the first intron of the mouse MED26 Fig. 4c ). The expression levels of mouse U1A1, U2, U3B, U5G and U11 snRNA genes, but not the expression level of the U6 snRNA gene, were significantly higher in MEF cells expressing MED26 wild type than in MEF cells expressing MED26-R61A, K62A (Fig. 5b) . These results indicate that MED26 NTD contributes to the expression of snRNA genes through the recruitment of LEC.
Region of EAF1 necessary for interaction with MED26 NTD
Since we previously found that EAF1 directly bound to MED26 NTD 20 , we carried out an experiment to determine the region of human EAF1 responsible for interaction with MED26
NTD. We tested whether recombinant proteins of a series of HA-EAF1 C-terminal deletion mutants bound to FLAG-MED26 NTD (Fig. 6a ). The full length (FL) of EAF1 bound to MED26 NTD, but the C-terminal deletion mutant N244 did not ( Fig. 6b ), indicating that carboxyl terminal amino acid residues from 245 to 268 in human EAF1 are required for interaction with MED26 NTD.
Comparison of MED26 NTD binding regions in EAF and TAF7
Since we previously found that EAF and TFIID bind to the overlapping binding site of MED26
NTD and that EAF1 recruitment by Mediator is inhibited by TFIID in vitro 20 , we considered the possibility that a certain TBP-associated factor (TAF) directly interacts with MED26 NTD. First, we investigated which TAFs directly interact with MED26 NTD. We performed in vitro binding assays using bacterially expressed GST-tagged MED26 and a pool of 13 kinds of human TAFs (from TAF1 to TAF13) expressed in a baculovirus expression system and tested which TAFs were pulled down by GST-MED26. We found that TAF1 and TAF7 were copurified with GST-MED26 but not with GST alone. To test whether TAF7 directly interacts with MED26
NTD, we performed in vitro binding assays using bacterially expressed FLAG-MED26 NTD and HA-TAF7. TAF7 directly interacted with MED26 NTD but not with MED26 NTD R61A, K62A ( Supplementary Fig. 5a ). In turn, TAF1 bound to MED26 NTD only in the presence of TAF7 ( Supplementary Fig. 5b ), suggesting that TAF1 interacted with MED26 NTD via TAF7
in the first binding assay with pooled TAFs. This result indicates that MED26 NTD interacts with not only free TAF7 but also TAF7 bound to TAF1, raising the possibility that MED26
NTD interacts with TAF7 in the context of TFIID. Since TAF7 is a subunit of TFIID, it is possible that expression of TAF7 as a single subunit results in aggregation and that recombinant protein of TAF7 does not exist as a monomer. To exclude this possibility, we tested whether recombinant HA-TAF7 and FLAG-TAF7 bind to each other. An in vitro binding assay revealed that HA-TAF7 bound to FLAG-MED26-NTD but not to FLAG-TAF7 ( Supplementary Fig. 5c ).
Although it is still possible that recombinant TAF7 proteins form a higher order state and do not bind to each other, our results suggest that recombinant TAF7 exists at least in part as a monomer. Taken together, our results showed that TAF7 directly bound to MED26 NTD.
Next, we investigated whether TAF7 harbors an amino acid sequence similar to that of the MED26 NTD binding region of EAF1. Sequence alignment revealed that the amino acid sequence from 219 to 235 in human TAF7 is partially similar to the amino acid sequence from 253 to 268 in human EAF1 (Fig. 6c) . Notably, both of the regions in TAF7 and EAF are conserved among species (Fig. 6c ). To determine whether the region of TAF7 is responsible for interaction with MED26 NTD, we generated recombinant proteins of a series of HA-TAF7
C-terminal deletion mutants ( were copurified with TFIID components TAF1 and TBP, but N129 was not (Fig. 6f ). These findings indicate that the region from 203 to 243 of TAF7 is dispensable for interaction with TAF1 or TFIID. Our results indicate that the distinct region of TAF7 contributes to interaction with MED26 and its incorporation into TFIID.
Point mutations of TAF7 and EAF1 block binding to MED26 NTD
We generated point mutants of EAF1 and TAF7 which lose interaction with MED26 NTD (Fig.   7a ). Mutations of S262, G263, S264 and D265 to A interfered with the interaction of EAF1 and MED26 NTD (Fig. 7b) . Similarly, mutations of S229, S230, E231 and D232 to A interfered with the interaction of TAF7 and MED26 NTD (Fig. 7c) . Consistent with the fact that the region of TAF7 is not well conserved in TAF7L (Fig. 7a ), TAF7L did not bind to MED26 NTD (Fig. 7d ). To test whether the region of TAF7 is critical for interaction with MED26 in cells, we generated HeLa cells stably expressing FLAG-tagged TAF7 wild type and point mutant (S229A, S230A, E231A, D232A) and purified TFIID (Fig. 7e) . Consistent with our results showing that the region of TAF7 is dispensable for interaction with TFIID ( Fig. 6f) , both the wild-type and point mutant copurified with similar levels of TFIID components TAF1 and TBP (Fig. 7f ). In contrast, the wild type of TAF7 copurified with MED26 and MED1, but the point mutant did not ( Fig. 7f) , demonstrating that the region of TAF7 is required for interaction with MED26-containing Mediator. These findings indicate the possibility that TAF7 in the context of TFIID and/or free TAF7 interact with MED26-containing Mediator.
TAF7 is present at snRNA genes
To test whether TAF7 is also present at snRNA genes, we compared the peaks of ICE1
(KIAA0947) ChIP-seq and TAF7 ChIP-seq. We identified 2912 TAF7-bound genes by TSS analysis ( ChIP-qPCR analysis also demonstrated that TAF7 was present at a subset of snRNA genes (Fig. 8f) .
Knockdown of TAF7 increases LEC recruitment to snRNA genes
Next, we tested how depletion of TAF7 in cells affects the expression of snRNA genes. We (Fig. 9a) . Knockdown of TAF7 mildly increased the expression of snRNA genes (Fig. 9b ).
Since partially similar amino acid sequences of TAF7 and EAF1 contribute to interaction with MED26 NTD, we considered the possibility that EAF1 and TAF7 bind to MED26 NTD in a mutually exclusive manner and that TAF7 inhibits EAF1 recruitment by Mediator. To test this possibility, we performed an immobilized template recruitment assay using an oligo(dC)-tailed template immobilized on Streptavidin beads (Fig. 9c) Fig. 7a ).
MED26-containing Mediator recruited EAF1 to the template, but MED26 mut (R61A, K62A)-containing Mediator did not ( Supplementary Fig. 7b ). Next, we performed immobilized template assays in the presence and absence of MED26-containing Mediator and recombinant proteins of EAF1 and N243 of TAF7 and tested whether TAF7 inhibits EAF1 recruitment by MED26-containing Mediator (Fig. 9c) . TAF7 N243 inhibited EAF1 recruitment by Mediator in a dose-dependent manner (Fig. 9d) , indicating that TAF7 N243 binds to MED26 NTD and blocks EAF1 recruitment (Fig. 9e ).
Next, we tested whether TAF7 knockdown increases the occupancy of LEC at snRNA genes in cells. TAF7 depletion moderately increased the occupancy of the components of LEC including ICE1, EAF2 and Pol II at U4-1 and U5B snRNA genes (Fig. 9f ), but it did not affect the occupancy of MED1 and MED26 at snRNA genes ( Supplementary Fig. 7c ). These findings suggest that TAF7 plays a role in repression of the transcription of a subset of snRNA genes through interfering with the recruitment of LEC to a subset of Pol II-transcribed snRNA genes.
Discussion
In this report, we present evidence that the human Mediator subunit MED26 contributes to the recruitment of LEC to a subset of Pol II-transcribed snRNA genes. MED26 depletion in cells decreased the expression of snRNA genes and the occupancy of LEC components at the genes. We found that EAF and TAF7 harbor a partially similar amino acid sequence that is necessary for direct interaction with MED26 NTD. We presented evidence that TAF7 is present at a subset of snRNA genes. We found that 
Immunoprecipitation and affinity purification
Protein complexes were purified from nuclear extracts or S100 fractions of cell lines stably expressing FLAG-tagged proteins using anti-FLAG M2 agarose (Sigma-Aldrich Corp.) as described previously 45 . Briefly, nuclear extracts and S100 fractions were prepared according to the method of Dignam et al. 46 from parental HeLa cells or HEK293 FRT cells stably expressing FLAG-tagged proteins. Each of the nuclear extracts or S100 fractions was incubated with 100 µl anti-FLAG agarose beads for 2 hr at 4°C. The beads were washed 5 times with a 100-fold excess of a buffer containing 50 mM Hepes-NaOH (pH 7.9), 0.3 M NaCl, 0.1% Triton X-100, and 10% (v/v) glycerol and then eluted with 100 µl of a buffer containing 0.1 M NaCl, 50 mM Hepes-NaOH (pH 7.9), 0.05% Triton X-100, 10% (v/v) glycerol and 0.25 mg ml -1 FLAG peptide.
Oligo(dC)-tailed template transcription assay
Transcription reactions were carried out in the presence of 20 mM Hepes-NaOH, pH 7.9/20 mM Fig. 2f , reaction mixtures were preincubated for 30 min at 28°C before the addition of ribonucleoside triphosphates. Reactions were stopped after incubation at 28°C for the times indicated in the figure, and products were resolved on 6% polyacrylamide gels containing 7 M urea, 45 mM Tris-borate and 1 mM EDTA (pH 8.3).
Generation of mouse embryonic fibroblast cells
ES cell line RRR660, in which the gene trapping construct pGT0lxf had been inserted into the first intron of one allele of the mouse MED26 gene, was purchased from Mutant Mouse
Regional Resource Center (MMRRC) at JAX. The ES cell line was injected into blastocysts of C57BL/6 mice, and chimera mice were generated. After heterozygous mice had been generated, or mutant (R61A, K62A) were generated by a Plat E retrovirus packaging system 47 .
Immobilized oligo(dC)-tailed template assays
A biotinylated oligo(dC)-tailed template generated from the plasmid pAd-GR220 was 
Gene expression analysis
Total RNA was isolated using Isogen II (Nippon gene, Tokyo, Japan). 
ChIP-seq and gene annotation
Sequencing reads were acquired through primary Solexa image analysis. Filtered leads were then aligned to the human genome (hg19) using the Bowtie alignment tool. Only those sequences that matched uniquely to the genome with up to two mismatches and mapped to less than 3 locations were retained for subsequent analyses. Sequence reads for each ChIP-sequence data set and its associated whole-cell extract controls were used for Input. Sequence reads from triplicate or single ChIP-sequence data set of ICE1 (KIAA0947) or TAF7 were used in analysis with the MACS2 peak finding program version 2.0.10, and significantly enriched regions of
ChIP-sequence signals were determined. Three of each data set from triplicate samples was summed up using MACS2. The significance cutoff was set to FDR<1% and a fold change between 5 and 50. All other MACS parameters were left default. Genes were identified if an enriched peak region was found within ±1kbp of the TSS of any transcript isoform of the gene.
The txStart positions of the Ensembl gene annotation were used for TSS analysis. 
Immunostaining
HeLa cells grown on glass coverslips were fixed for 7 min at room temperature with 100% methanol. Then the cells were incubated for 15 min with PBS containing 0.2% Triton X-100. 
